Verified peer comparison
ADMA Biologics Inc - Common Stock vs BridgeBio Pharma Financial Comparison
ADMA Biologics Inc - Common Stock versus BridgeBio Pharma using 2025 financials…
Direct answer
ADMA Biologics Inc - Common Stock and BridgeBio Pharma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- ADMA Biologics Inc - Common Stock Revenue
- 510,173,000 USD
- BridgeBio Pharma Revenue
- 502,078,000 USD
- ADMA Biologics Inc - Common Stock Operating income
- 191,443,000 USD
- BridgeBio Pharma Operating income
- -569,087,000 USD